Related Experiment Video

Updated: May 2, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.3K

Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect

M Lehto1, T Tuomi, M M Mahtani

  • 1Department of Endocrinology, Wallenberg Laboratory, Malmö University Hospital, Sweden.

The Journal of Clinical Investigation
|February 15, 1997
PubMed

Insights

Maturity-onset diabetes of the young (MODY) type 3, a genetic diabetes, involves severe insulin secretion impairment. This genetic defect, even in normoglycemic individuals, distinguishes it from other diabetes types like NIDDM and IDDM.

Area of Science:

  • Genetics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Maturity-onset diabetes of the young (MODY) type 3 is a dominantly inherited diabetes form.
  • It is frequently misdiagnosed as non-insulin-dependent diabetes mellitus (NIDDM) or insulin-dependent diabetes mellitus (IDDM).

Purpose of the Study:

  • To investigate the phenotypic characteristics of MODY type 3.
  • To differentiate MODY type 3 from NIDDM and IDDM based on clinical and genetic markers.

Main Methods:

  • Phenotypic analysis of members from four large Finnish MODY3 kindreds.
  • Genetic linkage analysis of chromosome 12q.

Main Results:

  • MODY3 is linked to chromosome 12q (lod score 15).
  • A severe impairment in insulin secretion was observed in affected individuals and normoglycemic carriers of the MODY3 gene.
  • MODY3 patients lacked features of insulin resistance syndrome and glutamic acid decarboxylase antibodies (GAD-Ab), distinguishing them from NIDDM and IDDM patients, respectively.

Conclusions:

  • Mutations in the MODY3/NIDDM2 gene(s) lead to reduced insulin secretion, progressing to diabetes.
  • Subphenotypic classification is crucial for diabetes research and accurate diagnosis.

More Related Videos

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

8.8K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17